We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

37 hedge funds and large institutions have $8.01M invested in PDS Biotechnology in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.15% less ownership

Funds ownership: 1.71% → 1.56% (-0.15%)

14% less funds holding

Funds holding: 43 → 37 (-6)

27% less capital invested

Capital invested by funds: $11M → $8.01M (-$3.02M)

50% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 14

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
37
Holders Change
-6
Holders Change %
-13.95%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$224K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$27.6K
3
PAM
Panagora Asset Management
Massachusetts
+$23.4K
4
BFM
Boothbay Fund Management
New York
+$17.7K
5
Renaissance Technologies
Renaissance Technologies
New York
+$15.2K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$401K
2
ARTA
A.R.T. Advisors
New York
-$186K
3
DS
DRW Securities
Illinois
-$103K
4
PP
Paloma Partners
Connecticut
-$99K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$87.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$10K -$1.91K -106 -14%
Creative Planning
27
Creative Planning
Kansas
$8K – – –
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
$5K – – –
Morgan Stanley
29
Morgan Stanley
New York
$2K -$49.6K -2,758 -96%
IA
30
IFP Advisors
Florida
$2K – – –
AIM
31
Advantage Investment Management
Iowa
$1K – – –
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$264 – – –
DS
33
DRW Securities
Illinois
– -$103K -5,001 Closed
PP
34
Paloma Partners
Connecticut
– -$99K -4,825 Closed
LP
35
LMR Partners
United Kingdom
– -$61K -2,964 Closed
VF
36
Virtu Financial
New York
– -$32K -1,557 Closed
Wellington Management Group
37
Wellington Management Group
Massachusetts
– -$29K -1,393 Closed
Bank of America
38
Bank of America
North Carolina
– -$12.5K -695 -98%
Deutsche Bank
39
Deutsche Bank
Germany
– -$8K -406 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$3K -128 Closed
MAM
41
Meeder Asset Management
Ohio
– -$1.38K -77 -82%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -51 Closed
Group One Trading
43
Group One Trading
Illinois
– -$449 -25 -50%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
– -$198 -11 -92%
1
2

PDSB Hedge Fund Activity: Q3 2018 in Review

37 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q3 2018, worth a combined $8.01M — down 27% from $11M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PDSB and 3 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 7 added.

The largest buyer was Ghost Tree Capital, adding an estimated $224K. The largest seller was Millennium Management, cutting an estimated $401K.

  • 37 institutional investors held PDS Biotechnology (PDSB) as of Q3 2018, down from 43 in Q2 2018.
  • Funds reported $8.01M of PDS Biotechnology stock for Q3 2018, down 27% quarter-over-quarter.
  • 3 funds opened new PDS Biotechnology positions in Q3 2018 and 9 closed out, a net change of -6 holders.
  • The largest PDS Biotechnology buyer in Q3 2018 was Ghost Tree Capital, an estimated $224K added.
  • The largest PDS Biotechnology seller in Q3 2018 was Millennium Management, an estimated $401K sold.

Based on aggregated 13F filings for Q3 2018.